Timing of solid food introduction and risk of obesity in preschool-aged children

Susanna Y Huh1, Sheryl L Rifas-Shiman, Elsie M Taveras

  • 1Division of Gastroenterology and Nutrition, Children's Hospital Boston, 300 Longwood Ave, Boston, MA 02115, USA. susanna.huh@childrens.harvard.edu

Pediatrics
|February 9, 2011
PubMed

Insights

Introducing solid foods before four months in formula-fed infants significantly increases obesity risk by age three. Breastfed infants showed no such association, highlighting the importance of feeding practices.

Area of Science:

  • Pediatric Nutrition
  • Public Health
  • Developmental Pediatrics

Background:

  • Infant feeding practices are crucial for long-term health outcomes.
  • Early introduction of solid foods is a debated topic in pediatric nutrition.
  • Childhood obesity is a growing public health concern with significant long-term implications.

Purpose of the Study:

  • To investigate the association between the timing of solid food introduction in infancy and the development of obesity at three years of age.
  • To differentiate this association based on infant feeding type (breastfed vs. formula-fed).

Main Methods:

  • Prospective birth cohort study (Project Viva) involving 847 children.
  • Exposure: Timing of solid food introduction (<4, 4-5, ≥6 months).
  • Outcome: Obesity at 3 years (BMI for age/gender ≥95th percentile), analyzed using logistic regression, adjusting for covariates.

Main Results:

  • Among formula-fed infants, introducing solids before 4 months was linked to a sixfold increase in obesity odds at age 3 (OR: 6.3; 95% CI: 2.3-6.9).
  • This association in formula-fed infants persisted even after adjusting for early growth markers.
  • No significant association was found between the timing of solid food introduction and obesity in breastfed infants.

Conclusions:

  • Early introduction of solid foods (before 4 months) is associated with increased odds of obesity at age 3 years in formula-fed infants.
  • The findings suggest that feeding type modifies the impact of solid food introduction timing on childhood obesity risk.
  • These results underscore the importance of age-appropriate introduction of solids, particularly for formula-fed infants.
Abstract

Related Concept Videos

Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...